ipo
Stage
2007
Founded
4
Investors
About
Quanterix develops ultra-sensitive digital immunoassay technology and instruments (Simoa) for biomarker detection, providing assays and platforms to research and clinical laboratories.
Explore Quanterix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.